We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
7 hedge funds and large institutions have $186K invested in Decoy Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
75% more funds holding
Funds holding: 4 → 7 (+3)
68% more capital invested
Capital invested by funds: $111K → $186K (+$75.1K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
7
Holders Change
+3
Holders Change %
+75%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HKAM
Horizon Kinetics Asset Management
New York
|
+$74K |
| 2 |
Two Sigma Investments
New York
|
+$22.5K |
| 3 |
Renaissance Technologies
New York
|
+$9.65K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.22K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$48.3K |